| 1 |
herpes simplex virus type 2
(1748 times)
|
Virology
(421 times)
|
HSV-1 (159 times)
CI (117 times)
HIV (113 times)
|
1971 Properties of hamster embryo fibroblasts transformed in vitro after exposure to ultraviolet-irradiated herpes simplex virus type 2.
|
| 2 |
herpes simplex virus 2
(396 times)
|
Virology
(90 times)
|
HSV-1 (32 times)
HIV (21 times)
HPV (20 times)
|
0 [Herpes simplex virus infection: an overview of the problem, pharmacologic therapy and dietary measures].
|
| 3 |
HSV type 2
(114 times)
|
Virology
(39 times)
|
HSV (92 times)
HSV-1 (50 times)
PCR (9 times)
|
1974 Virus type-specific thymidine kinase in cells biochemically transformed by herpes simplex virus types 1 and 2.
|
| 4 |
herpes virus type 2
(12 times)
|
Medicine
(2 times)
|
CMV (3 times)
EBV (2 times)
CIN (1 time)
|
1976 Clonal derivatives of a herpes type 2 transformed hamster cell line (333-8-9): cytogenetic analysis, tumorigenicity and virus sequence detection.
|
| 5 |
anti-herpes simplex virus 2
(2 times)
|
Biotechnology
(1 time)
|
EO (1 time)
mAbs (1 time)
|
1998 A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes.
|
| 6 |
anti-herpes virus type 2
(1 time)
|
Communicable Diseases
(1 time)
|
2,4-DTBP (1 time)
CM (1 time)
CT (1 time)
|
2019 Isolation of an antiviral compound from Tunisian olive twig cultivars.
|
| 7 |
herpes simplex virus 2 antibodies
(1 time)
|
Sexually Transmitted Diseases
(1 time)
|
TP (1 time)
|
2011 HIV and other sexually transmitted infections in a cohort of women involved in high-risk sexual behavior in Kampala, Uganda.
|
| 8 |
herpes simplex virus type 1 and type 2
(1 time)
|
Anti-Bacterial Agents
(1 time)
|
i.p (1 time)
|
1986 Antiherpetic effects of a human alpha interferon analog, IFN-alpha Con1, in hamsters.
|
| 9 |
herpes simplex virus type 2 prevalence
(1 time)
|
Reproductive Medicine
(1 time)
|
HPV (1 time)
MPTs (1 time)
SRH (1 time)
|
2016 Multipurpose prevention technologies for sexual and reproductive health: mapping global needs for introduction of new preventive products.
|
| 10 |
herpes simplex virus type-2 seropositivity
(1 time)
|
Public Health
(1 time)
|
---
|
2011 Prevalence of specific herpes simplex virus-2 antibodies and associated factors in women of a rural town of Colombia.
|
| 11 |
herpes simplex virus, type 2, strain G
(1 time)
|
Virology
(1 time)
|
---
|
1978 Suppression of the synthesis of cellular macromolecules by herpes simplex virus.
|
| 12 |
herpes, caused by simplex virus type 2
(1 time)
|
Public Health
(1 time)
|
---
|
2013 Prevalence of Chlamydia trachomatis and herpes simplex virus type 2: Results from the 2009 to 2011 Canadian Health Measures Survey.
|
| 13 |
HSV genome revealed that 112 (93.3%) were type-2
(1 time)
|
Sexually Transmitted Diseases
(1 time)
|
DNA (1 time)
HSV (1 time)
RE (1 time)
|
1990 Restriction endonuclease analysis of deoxyribonucleic acid (DNA) from genital herpes simplex virus type 2 isolates in Thailand.
|
| 14 |
HSV type common clones
(1 time)
|
Allergy and Immunology
(1 time)
|
CTL (1 time)
HSV (1 time)
HSV-1 (1 time)
|
1984 Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
|
| 15 |
HSV-2 vaccine preparations against homologous
(1 time)
|
Allergy and Immunology
(1 time)
|
IFN-gamma (1 time)
IL-2 (1 time)
IL-4 (1 time)
|
2000 Antibody responses, cytokine levels and protection of mice immunised with HSV-2 antigens formulated into NISV or ISCOM delivery systems.
|
A Search Service for Abbreviation / Long Form